| (R)-carnitine | multiple interactions | EXP | | 6480464 | Carnitine promotes the reaction [[Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate] | CTD | PMID:21816645 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10392 | 6480464 | Ethinyl Estradiol results in increased expression of CPT2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CPT2 mRNA | CTD | PMID:20106945 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:2398 | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of CPT2 protein] | CTD | PMID:21136691 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10392 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CPT2 mRNA | CTD | PMID:19465110 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10392 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CPT2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2398 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CPT2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2398 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CPT2 mRNA | CTD | PMID:22298810 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2398 | 6480464 | 2,4-dinitrotoluene affects the expression of CPT2 mRNA | CTD | PMID:21346803 |
| ammonium chloride | affects expression | ISO | RGD:2398 | 6480464 | Ammonium Chloride affects the expression of CPT2 mRNA | CTD | PMID:16483693 |
| ATP | multiple interactions | EXP | | 6480464 | [Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate; more ... | CTD | PMID:21816645 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10392 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CPT2 mRNA | CTD | PMID:21715664 |
| bezafibrate | increases expression | ISO | RGD:2398 | 6480464 | Bezafibrate results in increased expression of CPT2 mRNA | CTD | PMID:16707586 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of CPT2 mRNA | CTD | PMID:21816645 |
| bezafibrate | multiple interactions | EXP | | 6480464 | [Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate; more ... | CTD | PMID:21816645 |
| bezafibrate | increases activity | EXP | | 6480464 | Bezafibrate results in increased activity of CPT2 protein | CTD | PMID:21816645 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:10392 | 6480464 | Diethylhexyl Phthalate results in increased expression of CPT2 mRNA | CTD | PMID:19245819 |
| cadmium dichloride | decreases expression | ISO | RGD:2398 | 6480464 | Cadmium Chloride results in decreased expression of CPT2 protein | CTD | PMID:21699967 |
| clofibrate | multiple interactions | ISO | RGD:10392 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CPT2 mRNA] | CTD | PMID:17585979 |
| clofibrate | increases expression | ISO | RGD:2398 | 6480464 | Clofibrate results in increased expression of CPT2 mRNA | CTD | PMID:11328961 |
| clofibrate | decreases expression | ISO | RGD:2398 | 6480464 | Clofibrate results in decreased expression of CPT2 protein | CTD | PMID:20118634 |
| clofibrate | increases expression | ISO | RGD:2398 | 6480464 | Clofibrate results in increased expression of CPT2 protein | CTD | PMID:16470657 |
| clofibric acid | affects expression | ISO | RGD:2398 | 6480464 | Clofibric Acid affects the expression of CPT2 mRNA | CTD | PMID:17602206 |
| clozapine | multiple interactions | ISO | RGD:2398 | 6480464 | [Clozapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased activity of CPT2 protein; more ... | CTD | PMID:23226405 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CPT2 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CPT2 mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | decreases expression | ISO | RGD:10392 | 6480464 | Dibutyl Phthalate results in decreased expression of CPT2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:10392 | 6480464 | Dibutyl Phthalate results in decreased expression of CPT2 mRNA | CTD | PMID:17361019 PMID:21266533 |
| diuron | increases expression | ISO | RGD:2398 | 6480464 | Diuron results in increased expression of CPT2 mRNA | CTD | PMID:21551480 |
| doxorubicin | decreases expression | ISO | RGD:2398 | 6480464 | Doxorubicin results in decreased expression of CPT2 mRNA | CTD | PMID:19915844 |
| fenofibrate | increases expression | ISO | RGD:2398 | 6480464 | Fenofibrate results in increased expression of CPT2 mRNA | CTD | PMID:16707586 |
| fenofibrate | increases expression | ISO | RGD:2398 | 6480464 | Fenofibrate results in increased expression of CPT2 mRNA | CTD | PMID:16707586 PMID:19395589 |
| fenofibrate | decreases expression | ISO | RGD:2398 | 6480464 | Fenofibrate results in decreased expression of CPT2 protein | CTD | PMID:20118634 |
| flutamide | decreases expression | ISO | RGD:10392 | 6480464 | Flutamide results in decreased expression of CPT2 mRNA | CTD | PMID:17702527 |
| hydrazine | increases expression | ISO | RGD:10392 | 6480464 | hydrazine results in increased expression of CPT2 mRNA | CTD | PMID:15282401 |
| isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of CPT2 mRNA | CTD | PMID:20436886 |
| lithocholic acid | decreases expression | ISO | RGD:10392 | 6480464 | Lithocholic Acid results in decreased expression of CPT2 mRNA | CTD | PMID:20359477 |
| nicotinic acid | decreases expression | EXP | | 6480464 | Niacin results in decreased expression of CPT2 mRNA | CTD | PMID:19131065 |
| olanzapine | multiple interactions | ISO | RGD:2398 | 6480464 | [olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in decreased expression of CPT2 mRNA; more ... | CTD | PMID:23226405 |
| paracetamol | decreases expression | ISO | RGD:10392 | 6480464 | Acetaminophen results in decreased expression of CPT2 mRNA | CTD | PMID:17585979 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CPT2 mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:10392 | 6480464 | Acetaminophen affects the expression of CPT2 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:10392 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CPT2 mRNA; more ... | CTD | PMID:17585979 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:10392 | 6480464 | perfluorooctane sulfonic acid affects the expression of CPT2 mRNA | CTD | PMID:19429403 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:10392 | 6480464 | perfluorooctane sulfonic acid results in increased expression of CPT2 mRNA | CTD | PMID:20936131 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:2398 | 6480464 | perfluorooctane sulfonic acid results in increased expression of CPT2 mRNA | CTD | PMID:18692542 |
| perfluorooctanoic acid | affects expression | ISO | RGD:10392 | 6480464 | perfluorooctanoic acid affects the expression of CPT2 mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:10392 | 6480464 | PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CPT2 mRNA] | CTD | PMID:18467677 PMID:20936131 |
| perfluorooctanoic acid | increases expression | ISO | RGD:10392 | 6480464 | perfluorooctanoic acid results in increased expression of CPT2 mRNA | CTD | PMID:18467677 PMID:20936131 |
| perfluorooctanoic acid | increases expression | ISO | RGD:2398 | 6480464 | perfluorooctanoic acid results in increased expression of CPT2 mRNA | CTD | PMID:19162173 PMID:16221955 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:10392 | 6480464 | PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CPT2 mRNA] | CTD | PMID:18467677 |
| perfluorooctanoic acid | increases expression | ISO | RGD:2398 | 6480464 | perfluorooctanoic acid results in increased expression of CPT2 mRNA | CTD | PMID:16221955 PMID:19162173 |
| perfluorooctanoic acid | increases expression | ISO | RGD:10392 | 6480464 | perfluorooctanoic acid results in increased expression of CPT2 mRNA | CTD | PMID:18467677 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CPT2 mRNA | CTD | PMID:19159669 |
| phlorizin | decreases expression | ISO | RGD:10392 | 6480464 | Phlorhizin results in decreased expression of CPT2 mRNA | CTD | PMID:22538082 |
| piperonyl butoxide | increases expression | ISO | RGD:2398 | 6480464 | Piperonyl Butoxide results in increased expression of CPT2 mRNA | CTD | PMID:22484513 |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:15375163 more ... |
| pirinixic acid | increases expression | ISO | RGD:2398 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:16707586 more ... |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:15375163 more ... |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:2398 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:16940010 more ... |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:15375163 more ... |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:2398 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:16707586 more ... |
| pirinixic acid | increases expression | ISO | RGD:10392 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:15375163 more ... |
| pirinixic acid | increases expression | ISO | RGD:2398 | 6480464 | pirinixic acid results in increased expression of CPT2 mRNA | CTD | PMID:16707586 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:10392 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CPT2 mRNA] | CTD | PMID:17950772 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CPT2 mRNA | CTD | PMID:21632981 |
| rosiglitazone | affects expression | ISO | RGD:10392 | 6480464 | rosiglitazone affects the expression of CPT2 protein | CTD | PMID:21347706 |
| rosiglitazone | increases expression | ISO | RGD:2398 | 6480464 | rosiglitazone results in increased expression of CPT2 mRNA | CTD | PMID:21515302 |
| rosiglitazone | affects expression | ISO | RGD:10392 | 6480464 | rosiglitazone affects the expression of CPT2 mRNA | CTD | PMID:22013433 |
| streptozocin | increases expression | ISO | RGD:2398 | 6480464 | Streptozocin results in increased expression of CPT2 protein | CTD | PMID:21136691 |
| streptozocin | multiple interactions | ISO | RGD:2398 | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of CPT2 protein] | CTD | PMID:21136691 |
| trichloroethene | increases expression | ISO | RGD:10392 | 6480464 | Trichloroethylene results in increased expression of CPT2 mRNA | CTD | PMID:19448997 |
| troglitazone | increases expression | ISO | RGD:10392 | 6480464 | troglitazone results in increased expression of CPT2 mRNA | CTD | PMID:12732648 |
| troglitazone | increases expression | ISO | RGD:2398 | 6480464 | troglitazone results in increased expression of CPT2 mRNA | CTD | PMID:21515302 |
| troglitazone | increases expression | ISO | RGD:2398 | 6480464 | troglitazone results in increased expression of CPT2 protein | CTD | PMID:21315101 |
| zinc atom | decreases expression | ISO | RGD:2398 | 6480464 | Zinc deficiency results in decreased expression of CPT2 mRNA | CTD | PMID:15671213 |
| zinc(0) | decreases expression | ISO | RGD:2398 | 6480464 | Zinc deficiency results in decreased expression of CPT2 mRNA | CTD | PMID:15671213 |